Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 1
15(83.3%)
Phase 3
1(5.6%)
Phase 2
1(5.6%)
Phase 4
1(5.6%)
18Total
Phase 1(15)
Phase 3(1)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT07489183Completed

A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older

Role: lead

NCT06875193Phase 4Recruiting

DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes

Role: lead

NCT05823883Phase 1Unknown

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.

Role: lead

NCT05823870Phase 1Completed

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.

Role: lead

NCT05874180Phase 1Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition

Role: lead

NCT05874167Phase 1Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Role: lead

NCT05403281Phase 1Completed

A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Role: lead

NCT03282825Phase 1Unknown

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Role: lead

NCT03127046Phase 1Unknown

Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

Role: lead

NCT01654601Phase 1Completed

A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg

Role: lead

NCT01935167Phase 2Completed

To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy

Role: lead

NCT02004327Phase 1Completed

The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

Role: lead

NCT02212756Phase 1Completed

Pharmacokinetic Profiles of Metformin With DW1029M

Role: lead

NCT02212795Phase 1Completed

Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin

Role: lead

NCT02212782Phase 1Completed

the Pharmacokinetic Profiles of Linagliptin With DW1029M

Role: lead

NCT02212769Phase 1Completed

the Pharmacokinetic Profiles of Losartan With DW1029M

Role: lead

NCT01658020Phase 3Completed

A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg

Role: lead

NCT01367080Phase 1Completed

A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg

Role: lead

NCT01341249Phase 1Completed

A Study to Compare the Pharmacokinetic Profiles of DW224aa and DW224a

Role: collaborator

All 19 trials loaded